MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 37 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,994 | +8.8% | 21,611 | 0.0% | 0.00% | – |
| Q2 2023 | $61,591 | -28.9% | 21,611 | -1.8% | 0.00% | – |
| Q1 2023 | $86,676 | -50.5% | 21,999 | -50.2% | 0.00% | – |
| Q4 2022 | $174,976 | -13.4% | 44,186 | +100.9% | 0.00% | – |
| Q3 2022 | $202,000 | +57.8% | 21,996 | +1.8% | 0.00% | – |
| Q2 2022 | $128,000 | -8.6% | 21,608 | -0.9% | 0.00% | – |
| Q1 2022 | $140,000 | +2.9% | 21,802 | +4.7% | 0.00% | – |
| Q4 2021 | $136,000 | +16.2% | 20,832 | +1.9% | 0.00% | – |
| Q3 2021 | $117,000 | +28.6% | 20,448 | +23.0% | 0.00% | – |
| Q2 2021 | $91,000 | -8.1% | 16,626 | -2.3% | 0.00% | – |
| Q1 2021 | $99,000 | -13.2% | 17,016 | 0.0% | 0.00% | – |
| Q4 2020 | $114,000 | -11.6% | 17,016 | -3.1% | 0.00% | – |
| Q3 2020 | $129,000 | – | 17,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |